Skip to main content
FinSpry Logo
FinSpry
TAK logo
TAK
(NYSE)
Takeda Pharmaceutical Company Limited
$18.45-- (--)
Loading... - Market loading
OverviewFinancialsForecastStatisticsDividendsHistoricalProfile

Takeda Pharmaceutical Company (TAK) Stock Price & Financial Analysis

Takeda Pharmaceutical Company Stock Price Chart

Price Chart

Loading chart...

Financial Metrics & Key Statistics

Fundamental metrics, valuation ratios, and profitability indicators

Day's Range$18.39 - $18.54
52-Week High$18.90
52-Week Low$12.99
Open$18.48
Volume1.50M
Average Volume (3M)3.00M
Market Cap58.30B
Shares Outstanding3.16B
P/E Ratio (TTM)49.00
Forward P/E37.14
Price to Sales (P/S)1.93
Price to Book (P/B)1.75
EV/EBITDA10.60
Revenue (TTM)30.23B
Net Income (TTM)1.19B
Free Cash Flow (TTM)5.03B
EPS (TTM)$0.37
Profit Margin3.94%
Operating Margin11.90%
Return on Equity (ROE)3.58%
Debt to Equity0.88
50-Day MA$17.29
200-Day MA$16.76
52-Week Change19.81%
Annual Dividend$0.97
Dividend Yield5.25%
Payout Ratio200.00%
Last Dividend Ex-DateJul 6, 2027

Frequently Asked Questions About Takeda Pharmaceutical Company

What is the current stock price for TAK?

As of the latest trading session, TAK stock trades at $18.45. The 52-week range is $12.99–$18.90, with a day range of $18.39–$18.54.

What is the P/E ratio for TAK?

Takeda Pharmaceutical Company's trailing P/E ratio is 49.0, meaning investors pay $49.0 for every $1 of annual earnings. The forward P/E is 37.1, reflecting analyst expectations for future earnings. Takeda Pharmaceutical Company operates in the Healthcare sector.

Does TAK pay dividends?

Yes, Takeda Pharmaceutical Company pays a 5.25% annual dividend yield ($0.97 per share). The payout ratio is 200.0%. The last ex-dividend date was 2027-07-06.

What do analysts recommend for TAK?

Based on 1 analyst, the consensus for TAK is Buy.

What is the market cap of TAK?

Takeda Pharmaceutical Company's market capitalization is $58.30B, classifying it as a large-cap company. Takeda Pharmaceutical Company operates in the Healthcare sector within the Drug Manufacturers - Specialty & Generic industry.